Lv56
1320 积分 2024-06-18 加入
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
15天前
已完结
Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors
23天前
已完结
Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit
1个月前
已完结
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
1个月前
已完结
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia
1个月前
已完结
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer
1个月前
已完结
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
1个月前
已完结
Endometrial cancer: an update on diagnosis, treatment and the role of molecular profiling
1个月前
已完结
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102
1个月前
已关闭
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
